Chemical Structure (Invokamet 01)
Invokamet Xr Tablet, Film Coated, Extended Release
Product Images NDC 50458-941
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Invokamet Xr (NDC 50458-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Invokamet 02)
Figure 1 (Invokamet 03)
Figure 2 (Invokamet 04)
Figure 3 (Invokamet 05)
This is not-available.*
Figure 4 (Invokamet 06)
Principal Display Panel (50 mg/500 mg Tablet Bottle Label)
Principal Display Panel (50 mg/1,000 mg Tablet Bottle Label)
Principal Display Panel (150 mg/500 mg Tablet Bottle Label)
Principal Display Panel (150 mg/1,000 mg Tablet Bottle Label)
Principal Display Panel (50 mg/500 mg Tablet Bottle Label)
Invokamet XR is a medication available in tablet form. Each tablet contains 50mg of canagliflozin and 500mg of metformin hydrochloride, and is extended-release. It is prescribed for a variety of medical conditions, and should be taken as directed by a healthcare professional. The medication should be stored within a specific temperature range, and should be kept out of the reach of children. It is dispensed with a medication guide, and can be stored in a pill box for up to 30 days.*
Principal Display Panel (50 mg/1000 mg Tablet Bottle Label)
Invokamet xR is a medicine manufactured by Janssen Ortho LLC, Gurabo, PR 00778, and licensed from Mitsubishi Tanabe Pharra Corporation. It contains 50 mg of canagliflozin and 1000 mg of metformin HCI, extended-release. The tablets should be stored at a temperature between 56°F and 86°F (15°C and 30°C) and away from children. The full prescribing information can be found in the package insert and the medication should be dispensed with a medication guide. It is recommended to store and dispense the medication in its original container but it can be stored in a pill box for up to 30 days.*
Principal Display Panel (150 mg/500 mg Tablet Bottle Label)
Invokamet' xR is a medication containing canagliflozin and metformin HCI in extended-release tablet form, with each tablet containing 150mg canagliflozin and 500mg metformin. The dosing information can be found on the package inset, and it should be stored at a temperature between 68-77°F (20-25°C), with excursions permitted between 59°F and 86°F (15°C and 30°C). This medication should be kept out of reach of children and can be stored in a pill box for up to 30 days. The product is manufactured by Janssen Ortho, LLC in Gurabo, PR 00778 and licensed from Mitsubishi Tanabe Pharma Corporation.*
Principal Display Panel (150 mg/1000 mg Tablet Bottle Label)
The text contains a mixture of letters, numbers, and symbols, making it difficult to understand. It may be a product label or packaging information for a drug called "Invokamet XrR" in doses of 150 mg/1000 mg. It is recommended that the medication be stored and dispensed in its original container and comes with a medication guide. Additionally, it may be stored in a pillbox for a period of up to 30 days. There is also a unique identification number included (NDC 50458-943-01). The remaining text is unclear and may not be useful.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
